U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07832734) titled 'Metabolomics and Transcriptomics of Low- and High-Grade Gliomas' on Sept. 09.
Brief Summary: The goal of this observational study is to better define the molecular profile of rare brain tumors (gliomas) based on the levels of their metabolites and transcripts (the intermediate step between DNA information and proteins).
The main question it aims to answer is to identify new brain tumour subgroups of clinical relevance that might explain the very different history these patients might follow.
Additionally, studies on gliomas require cellular cultures and animal models for the development of new medications, but these models are st...